Joshua Reed | Chief Financial Officer |
Todd Brady | Chief Executive Officer |
Neil Carnahan | Stifel |
Esther Hong | Janney |
Good morning and welcome to the Aldeyra Therapeutics Third Quarter 2018 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Joshua Reed, Chief Financial Officer. Mr.